Clinical Trial Update: A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients. [Phase 2]

View source ↗

Summary

Phase IIa trial evaluating FeNO measurements in asthmatic patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FF/VI (fluticasone furoate/vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2018-08-28